Roy F.P.M. Kruitwagen

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 599 citations · Full text

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 432 citations · Full text

Endometrial epithelial cells in peritoneal fluid during the early follicular phase

Roy F.P.M. Kruitwagen, Lambert G. Poels, Wim N.P. Willemsen et al. · Fertility and Sterility · 1991 · 205 citations

Early Follicular Phase, Endometriosis, Uterine Receptivity +10

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients

Iris J.G. Rutten, David P.J. van Dijk, Roy F.P.M. Kruitwagen et al. · Journal of Cachexia Sarcopenia and Muscle · 2016 · 198 citations · Full text

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2016 · 176 citations · Full text